Here’s what to know about how VapoRub can provide relief, who should use caution and who should avoid it altogether.

Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...

A new obesity drug that Eli Lilly is researching but hasn't approved is turning up online, even though it's not supposed to be available.

In today's Asking Eric column, R. Eric Thomas shares a reader's advice about how to deal with aches and pains as you age.

After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

The deals tout significant discounts for people who pay out of pocket for certain medications. But most people with insurance ...

SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...

What Changed in the Amgen Story Amgen’s fair value estimate has been adjusted slightly, moving from about US$322.88 per share ...

Q. I developed severe depression while taking Repatha, the injectable cholesterol lowering drug. It took me a horrible nine months to realize the drug was making me suicidal. If I wasn’t sleeping, I ...